Get startedLog in
    Picture of China SXT Pharmaceuticals logo

    SXTC — China SXT Pharmaceuticals Cashflow Statement

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapValue Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for China SXT Pharmaceuticals, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

    2020
    March 31st
    2021
    March 31st
    2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:20-F20-F20-F20-F20-F
    Standards:
    USG
    USG
    USG
    USG
    USG
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-10.3-2.75-5.74-5.93-3.1
    Depreciation
    Amortisation
    Deferred Taxes
    Non-Cash Items9.052.892.894.191.35
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital1.95-1.612.461.42-0.382
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Other Assets
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Taxes Payable
    Change in Other Liabilities
    Cash from Operating Activities0.934-1.320.268-0.081-1.93
    Capital Expenditures-0.407-0.093-0.062-0.071-0.007
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-5.09-5.710.0160.0580.033
    Purchase of Investments
    Other Investing Cash Flow
    Cash from Investing Activities-5.5-5.81-0.047-0.0120.026
    Financing Cash Flow Items-3.712.5-3.84-3.26-1.73
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities3.0212.41.62.94-2.62
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-26.072.211.8-5.29